NIOX Group Plc (LON:NIOX) Insider Ian Johnson Purchases 144,844 Shares

NIOX Group Plc (LON:NIOXGet Free Report) insider Ian Johnson acquired 144,844 shares of the stock in a transaction dated Wednesday, June 25th. The shares were bought at an average price of GBX 8 ($0.11) per share, with a total value of £11,587.52 ($15,901.63).

Ian Johnson also recently made the following trade(s):

  • On Tuesday, May 20th, Ian Johnson sold 3,924,630 shares of NIOX Group stock. The stock was sold at an average price of GBX 65 ($0.89), for a total value of £2,551,009.50 ($3,500,767.81).

NIOX Group Trading Up 1.2%

LON NIOX opened at GBX 65.60 ($0.90) on Friday. NIOX Group Plc has a 1 year low of GBX 53.40 ($0.73) and a 1 year high of GBX 80 ($1.10). The company has a debt-to-equity ratio of 1.10, a current ratio of 6.31 and a quick ratio of 1.94. The company has a market capitalization of £26.94 billion, a PE ratio of 2,707.20 and a beta of 0.92. The company has a fifty day moving average of GBX 65.64 and a 200 day moving average of GBX 64.36.

NIOX Group (LON:NIOXGet Free Report) last released its quarterly earnings data on Tuesday, April 1st. The company reported GBX 2.27 ($0.03) earnings per share for the quarter. NIOX Group had a return on equity of 13.29% and a net margin of 28.21%. Research analysts forecast that NIOX Group Plc will post 1.1658256 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on NIOX shares. Berenberg Bank reissued a “buy” rating and issued a GBX 90 ($1.24) price objective on shares of NIOX Group in a report on Tuesday, April 15th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 90 ($1.24) price target on shares of NIOX Group in a report on Tuesday, April 15th.

Get Our Latest Report on NIOX Group

About NIOX Group

(Get Free Report)

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.

Read More

Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.